Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marie Saint-Remy

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Human Gene Therapy|March 18, 2003
Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependentWim Janssens, Marinee K L Chuah, Luigi Naldini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2Roxana R Ahangarani, Wim Janssens, Vincent Carlier, et al.
Journal of Molecular Biology|January 13, 2009
Crystal structures of mite allergens Der f 1 and Der p 1 reveal differences in surface-exposed residues that may influence antibody bindingMaksymilian Chruszcz, Martin D Chapman, Lisa D Vailes, et al.
Thorax|March 24, 2012
Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary diseaseManuela Rinaldi, An Lehouck, Nele Heulens, et al.
Blood|March 30, 2006
FVIII production by human lung microvascular endothelial cellsMarc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, et al.
Blood|April 5, 2003
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitorSylvie Villard, Sebastien Lacroix-Desmazes, Thomas Kieber-Emmons, et al.
Blood|September 13, 2003
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor developmentRoseline d'Oiron, Jean-Maurice Lavergne, Renaud Lavend'homme, et al.
Experimental Dermatology|November 21, 2012
Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c miceKrisztina Szalai, Tamara Kopp, Anna Lukschal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsivenessRoxana Roohi Ahangarani, Wim Janssens, Luc VanderElst, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Human Gene Therapy|March 18, 2003
Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependentWim Janssens, Marinee K L Chuah, Luigi Naldini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2Roxana R Ahangarani, Wim Janssens, Vincent Carlier, et al.
Journal of Molecular Biology|January 13, 2009
Crystal structures of mite allergens Der f 1 and Der p 1 reveal differences in surface-exposed residues that may influence antibody bindingMaksymilian Chruszcz, Martin D Chapman, Lisa D Vailes, et al.
Thorax|March 24, 2012
Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary diseaseManuela Rinaldi, An Lehouck, Nele Heulens, et al.
Blood|March 30, 2006
FVIII production by human lung microvascular endothelial cellsMarc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, et al.
Blood|April 5, 2003
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitorSylvie Villard, Sebastien Lacroix-Desmazes, Thomas Kieber-Emmons, et al.
Blood|September 13, 2003
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor developmentRoseline d'Oiron, Jean-Maurice Lavergne, Renaud Lavend'homme, et al.
Experimental Dermatology|November 21, 2012
Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c miceKrisztina Szalai, Tamara Kopp, Anna Lukschal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsivenessRoxana Roohi Ahangarani, Wim Janssens, Luc VanderElst, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Pageof 3